Company’s latest senior-level position announced amidst a period of continuous, fast-paced growth and expansion for AvevoRx.
Greensboro, N.C. – November 8, 2023 –AvevoRx, a national, independent provider of specialty infusion pharmacy services, has welcomed Denise Stechman as regional director of managed care. The senior-level position will see Ms. Stechman lead a robust payor-facing team charged with identifying and signing new managed care contracts for AvevoRx. Ms. Stechman will work with managed care organizations such as HMOs, PBMs, and other payor entities throughout Western U.S. markets to further support the company’s growth and geographic expansion.
Ms. Stechman brings to AvevoRx more than 30 years of experience, including several spent in payor and TPA industries. Most recently, she spent nearly two years as director of contracts for a specialty pharmacy. Prior to that role, she was an account manager for six years with United Healthcare UMR, where she oversaw a multi-million-dollar, multi-year contract for the state of Nevada – UHC’s largest client in the territory. Her focus was managing customer relationships to create retention and growth plans rooted in her detailed knowledge base of her customers. Ms. Stechman began her career as a pharmacy technician at just 19 years old.
She holds a Master of Arts in Judicial Management and a Bachelor of Arts in Criminal Justice (Pre-Law) from the University of Nevada at Reno, where she now lives.
“I have an innate passion for helping people and took an interest in healthcare and law very early on,” says Ms. Stechman. “Pharmacy offered me the chance to do everything I love – building relationships, working with payors large and small, and serving the most vulnerable patient populations to get the care they need. I am grateful to join a team that shares these values and is as obsessed as I am with simplifying the patient experience.”
“Our growth over the past year has been rapid, and we continuously see opportunities to partner with additional managed care plans in Western markets,” said Eric Hill, co-founder of AvevoRx. “Denise’s experience and focused leadership over this area ensures that we can build out a team to support new contracts for years to come and help reach as many patients as possible. A robust portfolio of managed care partners helps boost the level of service and simplicity we can offer them and payors alike.”
AvevoRx currently holds licenses in 26 states across the country. Visit AvevoRx.com for more information.
AvevoRx is a bespoke, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients facing various complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies for patients with short-term therapeutic needs on a regional basis. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit www.AvevoRx.com or follow us on Instagram or LinkedIn.